✦ LIBER ✦

High-dose chemotherapy with autologous stem cell support in poor-risk germ cell tumors

✍ Scribed by W. Siegert; O. Rick; J. Beyer

Publisher: Springer
Year: 1998
Tongue: English
Weight: 152 KB
Volume: 76
Category: Article
ISSN: 0939-5555
DOI: 10.1007/s002770050386

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hemolytic uremic syndrome after high dos

Hemolytic uremic syndrome after high dose chemotherapy with autologous stem cell support

✍ Hans Van Der Lelie; Joke W. Baars; Sjoerd Rodenhuis; Marjan A. Van Dijk; Coby W. 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 496 KB 👁 2 views

High-dose chemotherapy with hematopoieti

High-dose chemotherapy with hematopoietic stem-cell support in germ-cell tumor patient treatment: The French experience

✍ A. Fléchon; P. Biron; J.P. Droz 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 105 KB 👁 2 views

## Germ -cell tumors (GCTs) are very chemosensitive and highly curable cancers. For the small proportion of patients who fail conventional chemotherapy (CT), high-dose CT (HDCT) was introduced in France and elsewhere in 1982-1984. We report here on the French experience with HDCT in GCTs. At the C

High-dose chemotherapy and autologous pe

High-dose chemotherapy and autologous peripheral blood stem-cell transfusion after conventional chemotherapy for patients with high-risk Ewing's tumors

✍ Kazuhiro Tanaka; Tomoya Matsunobu; Akio Sakamoto; Shuichi Matsuda; Yukihide Iwam 📂 Article 📅 2002 🏛 Springer Japan 🌐 English ⚖ 62 KB

High-dose chemotherapy with autologous s

High-dose chemotherapy with autologous stem cell rescue for children with recurrent malignant brain tumors

✍ Chie-Schin Shih; Gregory A. Hale; Lindsey Gronewold; Xin Tong; Fred H. Laningham 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 129 KB 👁 1 views

## Abstract ## BACKGROUND. High‐dose chemotherapy (HDCT) with autologous stem cell rescue (ASCR) has been reported to be effective in treating children with recurrent central nervous system (CNS) malignancies. ## METHODS. To evaluate the efficacy and toxicities of HDCT and ASCR, the medical reco

High-dose chemotherapy with autologous h

High-dose chemotherapy with autologous hematopoietic stem-cell rescue for patients with malignant brain tumors

✍ Masato Kochi; Yukitaka Ushio 📂 Article 📅 1999 🏛 Springer ⚖ 91 KB

VAB-5 combination chemotherapy in progno

VAB-5 combination chemotherapy in prognostically poor risk patients with germ cell tumors

✍ Davor Vugrin; Willet F. Whitmore; Robert B. Golbey 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 429 KB 👁 2 views

Forty-four patients with nonseminomatous germ cell tumors with "poor prognostic features" were entered on the VAB-5 regimen and 38 are evaluable. VAB-5 represents an intensified version of the VAB-4 protocol. Poor prognostic features were considered to be bulky metastases (>5 cm in diameter), palpab